ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
ABEO | US
Overview
Corporate Details
- ISIN(s):
- US00289Y2063
- LEI:
- Country:
- United States of America
- Address:
- 6555 CARNEGIE AVE, 4TH FLOOR, 44103 CLEVELAND
- Website:
- https://abeonatherapeutics.com/
- Sector:
- Manufacturing
Description
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company that develops cell and gene therapies for serious and life-threatening rare diseases. The company's pipeline targets a range of genetic disorders, including recessive dystrophic epidermolysis bullosa (RDEB) and various ophthalmic conditions such as X-linked retinoschisis, Stargardt disease, and autosomal dominant optic atrophy. Abeona also has partnered programs in early clinical development for Sanfilippo syndrome and Batten disease. The company operates its own manufacturing facility, The Elisa Linton Center for Rare Disease Therapies, to support the development of its therapeutic candidates.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2008-06-10 18:37 | English | 7.2 KB | |||
| 2008-05-22 19:02 | English | 263.9 KB | |||
| 2008-05-22 17:50 |
PRIMARY DOCUMENT
|
English | 6.0 KB | ||
| 2008-05-22 17:11 |
PRIMARY DOCUMENT
|
English | 6.0 KB | ||
| 2008-05-20 19:04 |
FORM 10Q
|
English | 75.0 KB | ||
| 2008-05-15 17:59 |
NOT TIMELY 10Q
|
English | 9.0 KB | ||
| 2008-04-24 15:34 |
FORM 8-K
|
English | 9.5 KB | ||
| 2008-04-22 19:22 |
2008 PROXY
|
English | 104.7 KB | ||
| 2008-04-09 13:21 |
PRELIMINARY PROXY STATEMENT
|
English | 104.1 KB | ||
| 2008-03-31 18:44 |
FORM 10K
|
English | 241.7 KB | ||
| 2008-03-19 18:06 |
FORM 8-K
|
English | 10.4 KB | ||
| 2008-03-19 16:26 | English | 89.4 KB | |||
| 2008-03-14 16:03 |
AUTO-GENERATED PAPER DOCUMENT
|
English | 4.2 KB | ||
| 2008-03-11 14:09 |
FORM S-1
|
English | 1.0 MB | ||
| 2008-03-07 10:27 |
AMENDMENT NO. 4 TO SCHEDULE 13D
|
English | 252.6 KB |
Automate Your Workflow. Get a real-time feed of all ABEONA THERAPEUTICS INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ABEONA THERAPEUTICS INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ABEONA THERAPEUTICS INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
